Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4923895
- 85 Pages
- March 2022
- Medical Devices
The United States Human Immunodeficiency Virus (HIV)-1 Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Immunodeficiency Virus (HIV)-1 Therapeutics market, reaching US$ million by the year 2028. As for the Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Human Immunodeficiency Virus (HIV)-1 Therapeutics players cover AbbVie, Inc.(U.S.), Merck & Co., Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), and Boehringer Ingelheim GmbH (Germany), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Immunodeficiency Virus (HIV)-1 Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Labs
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AbbVie, Inc.(U.S.)
Merck & Co., Inc. (U.S.)
Bristol-Myers Squibb Company (U.S.)
Boehringer Ingelheim GmbH (Germany)
Genentech, Inc. (U.S.)
Cipla, Inc. (India)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2017-2028
2.1.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Segment by Type
2.2.1 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
2.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
2.2.3 Entry and Fusion Inhibitors
2.2.4 Protease Inhibitors (PIs)
2.2.5 Integrase Inhibitors
2.2.6 Coreceptor Antagonists
2.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
2.3.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Human Immunodeficiency Virus (HIV)-1 Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Labs
2.5 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
2.5.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2022)
3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Player
3.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Players
3.1.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Immunodeficiency Virus (HIV)-1 Therapeutics by Regions
4.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth (2017-2022)
4.3 APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth (2017-2022)
4.4 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022)
5.2 Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022)
5.3 Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2017-2022)
6.2 APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022)
6.3 APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics by Country (2017-2022)
7.2 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022)
7.3 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast
10.1.3 APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast
10.1.4 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast
10.1.5 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast
10.2 Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.2.2 Canada Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.2.3 Mexico Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.2.4 Brazil Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.3 APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast by Region (2023-2028)
10.3.1 China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.3.2 Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.3.3 Korea Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.3.4 Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.3.5 India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.3.6 Australia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.4 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.4.2 France Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.4.3 UK Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.4.4 Italy Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.4.5 Russia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.5 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.5.2 South Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.5.3 Israel Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.5.4 Turkey Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.5.5 GCC Countries Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Forecast
10.6 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast by Type (2023-2028)
10.7 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AbbVie, Inc.(U.S.)
11.1.1 AbbVie, Inc.(U.S.) Company Information
11.1.2 AbbVie, Inc.(U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
11.1.3 AbbVie, Inc.(U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AbbVie, Inc.(U.S.) Main Business Overview
11.1.5 AbbVie, Inc.(U.S.) Latest Developments
11.2 Merck & Co., Inc. (U.S.)
11.2.1 Merck & Co., Inc. (U.S.) Company Information
11.2.2 Merck & Co., Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
11.2.3 Merck & Co., Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Merck & Co., Inc. (U.S.) Main Business Overview
11.2.5 Merck & Co., Inc. (U.S.) Latest Developments
11.3 Bristol-Myers Squibb Company (U.S.)
11.3.1 Bristol-Myers Squibb Company (U.S.) Company Information
11.3.2 Bristol-Myers Squibb Company (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
11.3.3 Bristol-Myers Squibb Company (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bristol-Myers Squibb Company (U.S.) Main Business Overview
11.3.5 Bristol-Myers Squibb Company (U.S.) Latest Developments
11.4 Boehringer Ingelheim GmbH (Germany)
11.4.1 Boehringer Ingelheim GmbH (Germany) Company Information
11.4.2 Boehringer Ingelheim GmbH (Germany) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
11.4.3 Boehringer Ingelheim GmbH (Germany) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Boehringer Ingelheim GmbH (Germany) Main Business Overview
11.4.5 Boehringer Ingelheim GmbH (Germany) Latest Developments
11.5 Genentech, Inc. (U.S.)
11.5.1 Genentech, Inc. (U.S.) Company Information
11.5.2 Genentech, Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
11.5.3 Genentech, Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Genentech, Inc. (U.S.) Main Business Overview
11.5.5 Genentech, Inc. (U.S.) Latest Developments
11.6 Cipla, Inc. (India)
11.6.1 Cipla, Inc. (India) Company Information
11.6.2 Cipla, Inc. (India) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
11.6.3 Cipla, Inc. (India) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Cipla, Inc. (India) Main Business Overview
11.6.5 Cipla, Inc. (India) Latest Developments
12 Research Findings and Conclusion
Table 1. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Table 3. Major Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 4. Major Players of Entry and Fusion Inhibitors
Table 5. Major Players of Protease Inhibitors (PIs)
Table 6. Major Players of Integrase Inhibitors
Table 7. Major Players of Coreceptor Antagonists
Table 8. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2022)
Table 11. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2022)
Table 14. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Player (2020-2022)
Table 16. Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players Head office and Products Offered
Table 17. Human Immunodeficiency Virus (HIV)-1 Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Regions (2017-2022)
Table 22. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Country (2017-2022)
Table 24. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2022)
Table 26. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2022)
Table 28. APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Region (2017-2022)
Table 30. APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2022)
Table 32. APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2022)
Table 34. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Country (2017-2022)
Table 36. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2022)
Table 38. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Human Immunodeficiency Virus (HIV)-1 Therapeutics
Table 47. Key Market Challenges & Risks of Human Immunodeficiency Virus (HIV)-1 Therapeutics
Table 48. Key Industry Trends of Human Immunodeficiency Virus (HIV)-1 Therapeutics
Table 49. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 55. AbbVie, Inc.(U.S.) Details, Company Type, Human Immunodeficiency Virus (HIV)-1 Therapeutics Area Served and Its Competitors
Table 56. AbbVie, Inc.(U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
Table 57. AbbVie, Inc.(U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. AbbVie, Inc.(U.S.) Main Business
Table 59. AbbVie, Inc.(U.S.) Latest Developments
Table 60. Merck & Co., Inc. (U.S.) Details, Company Type, Human Immunodeficiency Virus (HIV)-1 Therapeutics Area Served and Its Competitors
Table 61. Merck & Co., Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
Table 62. Merck & Co., Inc. (U.S.) Main Business
Table 63. Merck & Co., Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Merck & Co., Inc. (U.S.) Latest Developments
Table 65. Bristol-Myers Squibb Company (U.S.) Details, Company Type, Human Immunodeficiency Virus (HIV)-1 Therapeutics Area Served and Its Competitors
Table 66. Bristol-Myers Squibb Company (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
Table 67. Bristol-Myers Squibb Company (U.S.) Main Business
Table 68. Bristol-Myers Squibb Company (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Bristol-Myers Squibb Company (U.S.) Latest Developments
Table 70. Boehringer Ingelheim GmbH (Germany) Details, Company Type, Human Immunodeficiency Virus (HIV)-1 Therapeutics Area Served and Its Competitors
Table 71. Boehringer Ingelheim GmbH (Germany) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
Table 72. Boehringer Ingelheim GmbH (Germany) Main Business
Table 73. Boehringer Ingelheim GmbH (Germany) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. Boehringer Ingelheim GmbH (Germany) Latest Developments
Table 75. Genentech, Inc. (U.S.) Details, Company Type, Human Immunodeficiency Virus (HIV)-1 Therapeutics Area Served and Its Competitors
Table 76. Genentech, Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
Table 77. Genentech, Inc. (U.S.) Main Business
Table 78. Genentech, Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Genentech, Inc. (U.S.) Latest Developments
Table 80. Cipla, Inc. (India) Details, Company Type, Human Immunodeficiency Virus (HIV)-1 Therapeutics Area Served and Its Competitors
Table 81. Cipla, Inc. (India) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Offered
Table 82. Cipla, Inc. (India) Main Business
Table 83. Cipla, Inc. (India) Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Cipla, Inc. (India) Latest Developments
List of Figures
Figure 1. Human Immunodeficiency Virus (HIV)-1 Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type in 2021
Figure 7. Human Immunodeficiency Virus (HIV)-1 Therapeutics in Hospitals
Figure 8. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Human Immunodeficiency Virus (HIV)-1 Therapeutics in Clinics
Figure 10. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Human Immunodeficiency Virus (HIV)-1 Therapeutics in Labs
Figure 12. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market: Labs (2017-2022) & ($ Millions)
Figure 13. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application in 2021
Figure 14. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Player in 2021
Figure 15. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Value Market Share by Country in 2021
Figure 21. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Consumption Market Share by Type in 2021
Figure 22. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application in 2021
Figure 23. United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Region in 2021
Figure 28. APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application in 2021
Figure 29. China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Country in 2021
Figure 36. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type in 2021
Figure 37. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application in 2021
Figure 38. Germany Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application in 2021
Figure 46. Egypt Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. France Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. UK Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
